DOGZ Nasdaq Miscellaneous Manufacturing Industries Financials FY2017βFY2026
Dogness (International) Corp had $15.9M of revenue in fiscal 2026, down 23.3% on the year before. Over five years, revenue changed +67.4% a year on average.
Hi! I read Dogness (International) Corpβs latest annual report (fiscal 2026). Here is what stands out:
Good So-so Weak
Are sales growing?
β23.3%
No. Sales fell 23.3% last year.
Does it make a profit?
β173.9%
No. It lost money last year.
Does profit turn into cash?
β49.7%
No. It spent more cash than it brought in.
How healthy are the accounts?
1 / 8
Weak. It passes 1 of 8 health tests.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Dogness (International) Corp did it, and the next one. Share prices often move a lot on those days.
Next results
September 30, 2027
Thursday Β· in 339 days
Estimated from the same quarter last year. It will be replaced by the announced date once there is one.
See who else reports that week β| Date | Results for | Time | Source |
|---|---|---|---|
| Oct 1, 2026 | Period ended Jun 30, 2026 | Time not announced | 20-F β |
| Oct 17, 2025 | Period ended Jun 30, 2025 | Before the market opens | 20-F β |
| Oct 17, 2024 | Period ended Jun 30, 2024 | Time not announced | 20-F β |
| Oct 12, 2023 | Period ended Jun 30, 2023 | Time not announced | 20-F β |
| Sep 30, 2022 | Period ended Jun 30, 2022 | After the market closes | 20-F β |
| Oct 29, 2021 | Period ended Jun 30, 2021 | After the market closes | 20-F β |
| Oct 30, 2020 | Period ended Jun 30, 2020 | After the market closes | 20-F β |
| Oct 29, 2019 | Period ended Jun 30, 2019 | After the market closes | 20-F β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· Dogness (International) Corp had $15.9M of revenue in fiscal 2026, down 23.3% on the year before. Over five years, revenue changed +67.4% a year on average. Its operating margin was β181.4%, down 148.6Β pts: of every 100 in sales, about β181 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Margins, % of revenue
KIRA Β· Dogness (International) Corp lost $27.6M in fiscal 2026.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$7.9M in fiscal 2026, β49.7% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
Cash, debt and the ratios that show how comfortably Dogness (International) Corp can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | $16.7M | $4.5M | $7.0M | $12.8M | $4.5M |
| Debt incl. finance leases | $6.9M | $5.4M | β | β | β |
| Net debt / EBITDA | β2.8x | β | β | β | β |
| Debt / equity | 0.1x | 0.1x | β | β | β |
| Interest coverage | 0.2x | β28.9x | β36.3x | β | β |
| Current ratio | 3.6x | 1.5x | 1.9x | 2.8x | 1.1x |
| Quick ratio | 3.1x | 1.2x | 1.6x | 2.3x | 0.9x |
| Total assets | $101M | $97.9M | $99.2M | $117M | $94.1M |
| Total liabilities | $12.3M | $21.5M | $22.8M | $19.1M | $19.1M |
| Shareholders' equity | $88.2M | $76.3M | $76.4M | $97.8M | $75.0M |
| Net debt (β = net cash) | β$9.8M | $1.0M | β | β | β |
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Dogness (International) Corp passes 1 of 8 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 9 | 2 / 9 | 3 / 9 | 5 / 9 | 8 / 9 | 1 / 9 | 5 / 8 | 5 / 8 | 1 / 8 |
| Accruals ratio | β3.2% | 2.5% | 3.9% | β9.4% | β2.8% | β3.0% | 1.7% | β7.0% | β5.8% | β24.1% |
| Altman Z'' | 3.50 | 11.68 | 10.22 | 3.77 | 2.14 | 8.87 | 3.40 | 3.35 | 5.31 | 0.81 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $21.2M | $30.1M | $25.9M | $19.2M | $1.2M | $2.2M | $1.7M | $0.1M | $20.7M | $15.9M |
| Net interest income | β$0.3M | β$0.0M | $0.6M | $0.0M | β$0.3M | β$0.4M | β | β | β | β |
| Provision for credit losses | $0.0M | $0.0M | β | β | β | β | β | β | β | β |
| Gross profit | $8.3M | $12.1M | $9.4M | $2.4M | $9.2M | $10.1M | $3.7M | $3.1M | $5.0M | $2.5M |
| Research and development | $0.2M | $0.6M | $0.7M | $1.5M | $0.5M | $0.9M | $0.9M | $0.6M | $1.1M | $1.0M |
| Operating income | $5.8M | $5.9M | $0.6M | β$8.7M | $1.9M | $0.1M | β$9.6M | β$7.5M | β$6.8M | β$28.8M |
| Interest expense | $0.3M | $0.0M | $0.2M | $0.2M | $0.3M | $0.4M | $0.3M | $0.2M | β$0.1M | β$0.1M |
| Pretax income | $5.9M | $5.5M | $1.8M | β$8.4M | $1.9M | $0.2M | β$8.7M | β$6.5M | β$6.2M | β$28.8M |
| Income tax | $0.9M | $0.9M | $0.4M | $0.2M | $0.6M | β$2.8M | β$1.2M | β$0.5M | β$1.1M | β$1.2M |
| Net income | $4.9M | $4.6M | $1.4M | β$8.4M | $1.5M | $3.2M | β$7.2M | β$6.1M | β$5.1M | β$27.6M |
| Diluted EPS | $0.33 | $0.22 | $0.05 | β$0.33 | $0.05 | $0.31 | β$0.68 | β$0.55 | β$0.38 | β$1.55 |
| Diluted shares | 0.02B | 0.02B | 0.03B | 0.03B | 0.03B | 0.01B | 0.01B | 0.01B | 0.01B | 0.02B |
| Cash flow | ||||||||||
| Cash from operations | $5.5M | $3.5M | β$1.3M | β$2.2M | $3.8M | $6.2M | β$8.9M | $0.8M | $1.1M | β$2.3M |
| Capital expenditure | $3.6M | $11.0M | $3.2M | $0.8M | $0.8M | $15.3M | $1.5M | $3.5M | $1.6M | $5.6M |
| Free cash flow | $1.9M | β$7.5M | β$4.4M | β$3.0M | $3.0M | β$9.1M | β$10.4M | β$2.7M | β$0.5M | β$7.9M |
| Depreciation and amortization | $0.8M | $1.2M | $1.5M | $2.3M | $3.1M | $3.5M | $3.3M | $2.8M | $2.8M | $2.7M |
| Stock-based compensation | β | β | $0.7M | $0.4M | $0.5M | $0.0M | $1.2M | $0.3M | $0.2M | β |
| Dividends paid | $2.7M | $0.0M | β | β | β | β | β | β | β | β |
| Dividends and buybacks | $2.7M | $0.0M | β | β | β | β | β | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.5M | $35.3M | $13.6M | $4.8M | $5.5M | $16.7M | $4.5M | $7.0M | $12.8M | $4.5M |
| Total debt | $5.9M | $4.8M | $2.9M | $0.1M | $8.1M | $6.9M | $5.4M | β | β | β |
| Current assets | $8.7M | $46.3M | $25.9M | $11.6M | $14.3M | $23.4M | $14.0M | $16.4M | $17.1M | $8.5M |
| Current liabilities | $10.2M | $9.0M | $8.1M | $10.8M | $21.3M | $6.5M | $9.3M | $8.5M | $6.1M | $7.6M |
| Inventory | $2.9M | $4.2M | $5.4M | $2.9M | $4.2M | $3.4M | $2.7M | $3.1M | $2.7M | $1.7M |
| Property and equipment, net | $8.8M | $21.0M | $35.5M | $43.5M | $69.9M | $68.4M | $61.7M | $61.3M | $58.3M | $58.3M |
| Intangible assets | $0.1M | $2.4M | $2.2M | $2.1M | $2.2M | $2.1M | $1.8M | $1.8M | $1.7M | $0.6M |
| Total assets | $17.5M | $69.7M | $69.0M | $63.6M | $93.8M | $101M | $97.9M | $99.2M | $117M | $94.1M |
| Total liabilities | $10.2M | $9.0M | $8.1M | $12.0M | $28.9M | $12.3M | $21.5M | $22.8M | $19.1M | $19.1M |
| Shareholders' equity | $7.4M | $60.7M | $60.8M | $50.9M | $64.4M | $88.2M | $76.3M | $76.4M | $97.8M | $75.0M |
| Margins | ||||||||||
| Gross margin | 39.4% | 40.3% | 36.4% | 12.5% | 758.1% | 458.2% | 215.3% | 3,076.6% | 24.3% | 16.0% |
| Operating margin | 27.4% | 19.7% | 2.5% | β45.5% | 153.8% | 3.3% | β562.5% | β7,419.6% | β32.8% | β181.4% |
| EBITDA margin | 31.4% | 23.8% | 8.1% | β33.6% | 411.0% | 159.6% | β367.5% | β4,688.9% | β19.4% | β164.3% |
| Net margin | 23.4% | 15.3% | 5.5% | β44.0% | 125.2% | 146.2% | β423.5% | β5,966.2% | β24.6% | β173.9% |
| FCF margin | 8.9% | β24.9% | β17.1% | β15.9% | 246.3% | β411.2% | β613.0% | β2,670.8% | β2.2% | β49.7% |
| Net interest share of revenue | β1.6% | β0.1% | 2.4% | 0.1% | β21.9% | β16.7% | β | β | β | β |
| Returns | ||||||||||
| Return on capital | 41.6% | 16.3% | 1.0% | β14.9% | 1.9% | 0.1% | β9.8% | β | β | β |
| Return on capital employed | 79.0% | 9.8% | 1.0% | β16.5% | 2.6% | 0.1% | β10.8% | β8.3% | β6.1% | β33.3% |
| Return on equity | 67.2% | 13.5% | 2.3% | β15.1% | 2.6% | 4.2% | β8.8% | β7.9% | β5.9% | β32.0% |
| Return on assets | 28.2% | 10.6% | 2.0% | β12.7% | 1.9% | 3.3% | β7.2% | β6.1% | β4.7% | β26.2% |
| Return on tangible equity | 68.0% | 7.9% | 2.4% | β17.3% | 2.4% | 3.8% | β9.7% | β8.1% | β5.3% | β37.1% |
| Growth | ||||||||||
| Revenue growth | β | 42.3% | β14.1% | β25.9% | β93.7% | 83.2% | β23.2% | β94.0% | 20,301.7% | β23.3% |
| Net income growth | β | β6.9% | β69.1% | β693.7% | β | 113.9% | β322.5% | β | β | β |
| EPS growth | β | β33.3% | β77.3% | β760.0% | β | 520.0% | β319.4% | β | β | β |
| FCF growth | β | β498.2% | β | β | β | β405.9% | β | β | β | β |
| Share count change | β | 38.7% | 24.7% | β0.1% | 6.3% | β62.6% | 2.7% | 3.0% | 22.8% | 32.8% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.7x | β4.3x | β5.1x | β | 0.5x | β2.8x | β | β | β | β |
| Debt / equity | 0.8x | 0.1x | 0.0x | 0.0x | 0.1x | 0.1x | 0.1x | β | β | β |
| Interest coverage | 17.5x | 247.6x | 3.0x | β36.4x | 7.0x | 0.2x | β28.9x | β36.3x | β | β |
| Current ratio | 0.9x | 5.2x | 3.2x | 1.1x | 0.7x | 3.6x | 1.5x | 1.9x | 2.8x | 1.1x |
| Quick ratio | 0.6x | 4.7x | 2.5x | 0.8x | 0.5x | 3.1x | 1.2x | 1.6x | 2.3x | 0.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 17.1% | 36.6% | 12.2% | 4.4% | 64.4% | 689.7% | 89.4% | 3,472.6% | 7.7% | 35.5% |
| Stock comp / revenue | β | β | 2.6% | 2.1% | 43.9% | 0.5% | 73.1% | 309.3% | 0.9% | β |
| Payouts / FCF | 144.4% | β | β | β | β | β | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 2.0 | 3.0 | 5.0 | 8.0 | 1.0 | 5.0 | 5.0 | 1.0 |
| Altman Z'' | 3.5 | 11.7 | 10.2 | 3.8 | 2.1 | 8.9 | 3.4 | 3.4 | 5.3 | 0.8 |
| Accruals ratio | β3.2% | 2.5% | 3.9% | β9.4% | β2.8% | β3.0% | 1.7% | β7.0% | β5.8% | β24.1% |
Source: SEC EDGAR XBRL filings (CIK 0001707303). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
